ConductScience.org, home

Paper35774792

microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate.

Dominguez-Mozo MI and 10 others. Front Immunol, 2022. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate. Papers, record 35774792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35774792

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
microRNA Expression and Its Association With Disability and Brain Atrophy in Multiple Sclerosis Patients Treated With Glatiramer Acetate.
PubMed
Journal
Front Immunol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.91
iCite
Revised in PubMed
2024-08-30
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Dominguez-Mozo MIMaría I
2Casanova IIgnacio
3De Torres LLaura
4Aladro-Benito YYolanda
5Perez-Perez SSilvia
6Garcia-Martínez AAngel
7Gomez PPatricia
8Abellan SSara
9De Antonio EEsther
10Lopez-De-Silanes CCarlos
11Alvarez-Lafuente RRoberto

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Central Nervous System DiseasesMajor topic
MicroRNAsMajor topic
Multiple SclerosisMajor topic
Neurodegenerative DiseasesMajor topic
Atrophy
Biomarkers
Brain
Cross-Sectional Studies
Glatiramer Acetate
Humans

Source PubMed

Download CSV of topics

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129043654Evaluation of Selected MicroRNAs Expression in Remission Phase of Multiple Sclerosis and Their Potential Link to Cognition, Depression, and Disability.J Mol Neurosci2017https://conductscience.org/library/papers/29043654PubMed
224901013Unraveling natalizumab effects on deregulated miR-17 expression in CD4+ T cells of patients with relapsing-remitting multiple sclerosis.J Immunol Res2014https://conductscience.org/library/papers/24901013PubMed
331638082MicroRNAs in blood and cerebrospinal fluid as diagnostic biomarkers of multiple sclerosis and to monitor disease progression.Neural Regen Res2020https://conductscience.org/library/papers/31638082PubMed
432199199miR-504 expression level is increased in multiple sclerosis patients responder to interferon-beta.J Neuroimmunol2020https://conductscience.org/library/papers/32199199PubMed
523494648Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.Ann Neurol2013https://conductscience.org/library/papers/23494648PubMed
612607150Minimal neuropsychological assessment of MS patients: a consensus approach.Clin Neuropsychol2002https://conductscience.org/library/papers/12607150PubMed
728872459miR-146a modulates autoreactive Th17 cell differentiation and regulates organ-specific autoimmunity.J Clin Invest2017https://conductscience.org/library/papers/28872459PubMed
822190573Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).Mult Scler2012https://conductscience.org/library/papers/22190573PubMed
919617918Differential micro RNA expression in PBMC from multiple sclerosis patients.PLoS One2009https://conductscience.org/library/papers/19617918PubMed
1031606972Comparison of The Expression of miR-326 between Interferon beta Responders and Non-Responders in Relapsing-Remitting Multiple Sclerosis.Cell J2020https://conductscience.org/library/papers/31606972PubMed
1124852919Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.Mult Scler2014https://conductscience.org/library/papers/24852919PubMed
1234179535Altered expression of microRNAs and B lymphocytes during Natalizumab therapy in multiple sclerosis.Heliyon2021https://conductscience.org/library/papers/34179535PubMed
1326954942MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response.Shock2016https://conductscience.org/library/papers/26954942PubMed
1425860297Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα.Arthritis Res Ther2015https://conductscience.org/library/papers/25860297PubMed
1520850013Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses.Cell2010https://conductscience.org/library/papers/20850013PubMed
1630126230The First Dose of Fingolimod Affects Circulating Extracellular Vesicles in Multiple Sclerosis Patients.Int J Mol Sci2018https://conductscience.org/library/papers/30126230PubMed
1725947625MicroRNA-572 expression in multiple sclerosis patients with different patterns of clinical progression.J Transl Med2015https://conductscience.org/library/papers/25947625PubMed
1823643683Consensus Statement on medication use in multiple sclerosis by the Spanish Society of Neurology's study group for demyelinating diseases.Neurologia2013https://conductscience.org/library/papers/23643683PubMed
1927725128Effect of fingolimod treatment on circulating miR-15b, miR23a and miR-223 levels in patients with multiple sclerosis.J Neuroimmunol2016https://conductscience.org/library/papers/27725128PubMed
2032432792Upregulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients.Acta Neurol Scand2020https://conductscience.org/library/papers/32432792PubMed

See all 62 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42511484MicroRNA Expression Profiles as Biomarkers of Response to Disease-Modifying Therapies in Multiple Sclerosis: A Systematic Review.Int J Mol Sci2026https://conductscience.org/library/papers/42511484PubMed
42032299Blood-derived microRNA signatures associated with hippocampal structure and atrophy rate: findings from the Rhineland Study.Mol Psychiatry2026https://conductscience.org/library/papers/42032299PubMed
40943658From Molecules to Models: miRNAs and Advanced Human Platforms of Neurodegeneration and Repair in Multiple Sclerosis.Int J Mol Sci2025https://conductscience.org/library/papers/40943658PubMed
40677715Short-term exposure to particulate matter triggers a selective alteration of plasma extracellular vesicle-packaged miRNAs in a mouse model of multiple sclerosis.Front Immunol2025https://conductscience.org/library/papers/40677715PubMed
39337499Association of MicroRNA Expression and Serum Neurofilament Light Chain Levels with Clinical and Radiological Findings in Multiple Sclerosis.Int J Mol Sci2024https://conductscience.org/library/papers/39337499PubMed
38255959Circulating microRNA miR-425-5p Associated with Brain White Matter Lesions and Inflammatory Processes.Int J Mol Sci2024https://conductscience.org/library/papers/38255959PubMed
37893133MicroRNAs Associated with Disability Progression and Clinical Activity in Multiple Sclerosis Patients Treated with Glatiramer Acetate.Biomedicines2023https://conductscience.org/library/papers/37893133PubMed
37881368Circulating microRNAs correlate with structural and functional MRI parameters in patients with multiple sclerosis.Front Mol Neurosci2023https://conductscience.org/library/papers/37881368PubMed

Download CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IFNB13456PubTator's text mininghttps://conductscience.org/library/genes/3456NCBI Gene
MBP4155PubTator's text mininghttps://conductscience.org/library/genes/4155NCBI Gene
MIR1263100302148PubTator's text mininghttps://conductscience.org/library/genes/100302148NCBI Gene
MIR155406947PubTator's text mininghttps://conductscience.org/library/genes/406947NCBI Gene
MIR191406966PubTator's text mininghttps://conductscience.org/library/genes/406966NCBI Gene
MIR30C1407031PubTator's text mininghttps://conductscience.org/library/genes/407031NCBI Gene
MIR326442900PubTator's text mininghttps://conductscience.org/library/genes/442900NCBI Gene
MIR95407052PubTator's text mininghttps://conductscience.org/library/genes/407052NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35774792

GET https://conductscience.org/api/papers/v1/35774792/references?page=2